WO2010010394A3 - Local pharmaceutical compositions comprising an extract of spilanthes - Google Patents
Local pharmaceutical compositions comprising an extract of spilanthes Download PDFInfo
- Publication number
- WO2010010394A3 WO2010010394A3 PCT/GB2009/050905 GB2009050905W WO2010010394A3 WO 2010010394 A3 WO2010010394 A3 WO 2010010394A3 GB 2009050905 W GB2009050905 W GB 2009050905W WO 2010010394 A3 WO2010010394 A3 WO 2010010394A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- spilanthes
- pharmaceutical compositions
- composition
- need
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Abstract
The present invention provides a composition adapted to supply locally to the site of need in a patient in need thereof a compound having a pharmaceutical activity, wherein the active agent of said composition comprises an extract of Spilanthes
oleracea. The composition is of particular use, for example, as an analgesic in providing rapid treatment of neuropathic pain and as a long-lasting anaesthetic. Compositions of the invention for buccal admininistration can preferably be in the form of lozenges, tablets or mucoadhesive gels.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0813395A GB0813395D0 (en) | 2008-07-22 | 2008-07-22 | Local pharmaceutical compositions |
GB0813395.1 | 2008-07-22 | ||
GB0908970A GB0908970D0 (en) | 2009-05-26 | 2009-05-26 | Local pharmaceutical compositions |
GB0908970.7 | 2009-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010010394A2 WO2010010394A2 (en) | 2010-01-28 |
WO2010010394A3 true WO2010010394A3 (en) | 2010-03-18 |
Family
ID=41479393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2009/050905 WO2010010394A2 (en) | 2008-07-22 | 2009-07-22 | Local pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010010394A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9877929B2 (en) | 2011-10-13 | 2018-01-30 | Premier Dental Products Company | Topical vitamin D and ubiquinol oral supplement compositions |
US9724542B2 (en) | 2012-10-12 | 2017-08-08 | Premier Dental Products Company | Remineralizing and desensitizing compositions, treatments and methods of manufacture |
US9877930B2 (en) * | 2012-10-12 | 2018-01-30 | Premier Dental Products Company | Topical ubiquinol oral supplement compositions with amorphous calcium phosphate |
JP6278417B2 (en) * | 2012-10-12 | 2018-02-14 | プレミア デンタル プロダクツ カンパニー | Topical oral supplement composition of vitamin D and ubiquinol |
US9522168B2 (en) | 2014-05-29 | 2016-12-20 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Acmella oleracea extracts and uses thereof |
EP3678658A4 (en) | 2017-09-08 | 2021-05-05 | Scicann Therapeutics Inc. | Compositions comprising a cannabinoid and spilanthol |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3720762A (en) * | 1970-07-11 | 1973-03-13 | Lion Hamigaki Kk | Spilanthol-containing compositions for oral use |
US20020122778A1 (en) * | 2000-12-15 | 2002-09-05 | Philip Wolfson | Herbal composition for improving oral hygiene, for providing local anesthesia, for use as an oral sensate, flavor enhancer and potentiator, and methods of using same |
JP2004189660A (en) * | 2002-12-10 | 2004-07-08 | Hayashibara Biochem Lab Inc | External preparation for skin and application thereof |
US20060141064A1 (en) * | 2004-12-28 | 2006-06-29 | Council Of Scientific & Industrial Research | Herbal formulation useful as local anesthetic |
-
2009
- 2009-07-22 WO PCT/GB2009/050905 patent/WO2010010394A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3720762A (en) * | 1970-07-11 | 1973-03-13 | Lion Hamigaki Kk | Spilanthol-containing compositions for oral use |
US20020122778A1 (en) * | 2000-12-15 | 2002-09-05 | Philip Wolfson | Herbal composition for improving oral hygiene, for providing local anesthesia, for use as an oral sensate, flavor enhancer and potentiator, and methods of using same |
JP2004189660A (en) * | 2002-12-10 | 2004-07-08 | Hayashibara Biochem Lab Inc | External preparation for skin and application thereof |
US20060141064A1 (en) * | 2004-12-28 | 2006-06-29 | Council Of Scientific & Industrial Research | Herbal formulation useful as local anesthetic |
Non-Patent Citations (2)
Title |
---|
CHAKRABORTY A ET AL: "LOCAL ANAESTHETIC EFFECT OF SPILANTHES ACMELLA IN EXPERIMENTAL ANIMAL MODELS", INDIAN JOURNAL OF PHARMACOLOGY, MEDKNOW PUBLICATIONS AND MEDIA PVT. LTD, IN, vol. 34, no. 2, 1 April 2002 (2002-04-01), pages 144/145, XP009035381, ISSN: 0253-7613 * |
DATABASE WPI Week 200940, Derwent World Patents Index; AN 2009-K39223, XP002562927 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010010394A2 (en) | 2010-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011044506A3 (en) | Sulphone compounds for use in the treatment of obesity | |
WO2008130320A3 (en) | Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
WO2010010394A3 (en) | Local pharmaceutical compositions comprising an extract of spilanthes | |
NZ594589A (en) | 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents | |
WO2006116731A3 (en) | Personal care compositions comprising a dipeptide | |
MX2010003258A (en) | Use of a novel natural agent in cosmetic compositions. | |
WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
MX2010002392A (en) | Improved brimonidine compositions for treating erythema. | |
WO2009141541A3 (en) | Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
WO2008074824A3 (en) | Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) | |
WO2008054698A3 (en) | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
RS53202B (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
WO2008042944A3 (en) | Non-irritating oral care formulations | |
IL204640A0 (en) | Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin | |
WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
MX2012005689A (en) | Arachidonic acid analogs and methods for analgesic treatment using same. | |
WO2010090494A3 (en) | Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof | |
WO2006108681A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria | |
UA96794C2 (en) | Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
TNSN08506A1 (en) | Substituted carboxamides | |
IN2011KN05169A (en) | ||
TNSN07203A1 (en) | Pharmaceutical compositions for the treatment of cellulite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC ( EPO FORM 1205A DATED 18.05.11 ) |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09785379 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09785379 Country of ref document: EP Kind code of ref document: A2 |